Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Impact of Psychomotricity on the Patients Body Experience in Palliative Care (PSYCHOMOTPAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03959813
Recruitment Status : Not yet recruiting
First Posted : May 22, 2019
Last Update Posted : May 22, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:

Palliative care is part of a comprehensive approach to the person, in the advanced phase of a serious illness. The purpose of this care is to relieve painful symptoms, to promote comfort and quality of life. In the context of a serious illness, the sick person is confronted with body modifications that have an impact on his body experience, that is, on his feelings and on the image that he has of his body.

Psychomotricity is a paramedical discipline that focuses on body-psyche links. The psychomotor therapist is authorized to take care of psychomotor disorders, as defined in the decree of competences. These psychomotor disorders appear in connection with the evolution of the serious illness and the presence of symptoms in these patients (ex: disorders of the tonic regulation, psychomotor disharmony, disorders of the representation of the body, etc.). In palliative care, the psychomotor therapist seeks to regulate these psychomotor disorders and thus to promote a more satisfying physical experience in the patient, through the use of different bodily approaches.

Several studies have shown the beneficial effects of touching and moving the body in cancer patients, but no work evaluating the effects of the psychomotor approach (involving various body mediations) on the body experience of patients with cancer in palliative situation


Condition or disease Intervention/treatment
Palliative Care Other: Psychomotricity by touching and passive mobilizations

Layout table for study information
Study Type : Observational
Estimated Enrollment : 38 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Impact of Psychomotricity on the Patients Body Experience in Palliative Care
Estimated Study Start Date : September 1, 2019
Estimated Primary Completion Date : November 1, 2021
Estimated Study Completion Date : November 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Palliative Care


Intervention Details:
  • Other: Psychomotricity by touching and passive mobilizations

    The patient will have a first psychomotricity session. It will be carried out remotely from the drug catches to avoid bias induced by their administration having effects on the symptoms studied.

    Before and after the session, two evaluations will be offered to the patient and performed by a nurse:

    • A questionnaire, based on the physical experience,
    • The ESAS scale will be administered to the patient to assess the importance of symptoms (pain, depression, anxiety, discomfort) During the session, a touch treatment will be offered to promote awareness of the body. Passive mobilizations at the level of the members and the axis will then be proposed, to promote the pleasure of being in motion. A touch treatment will be done again to promote relaxation.

    A questionnaire can be offered to the patient after 4 sessions to assess his perception of psychomotricity.



Primary Outcome Measures :
  1. Realization of a questionnaire, based on the patient's global and physical feeling [ Time Frame: 30 minutes before psychomotor care ]
    questionnaire used to assess the impact of psychomotor care on the body experience of patients with advanced palliative care cancer, in both a physical and psychological dimension

  2. Realization of a questionnaire, based on the patient's global and physical feeling [ Time Frame: 30 minutes after psychomotor care ]
    questionnaire used to assess the impact of psychomotor care on the body experience of patients with advanced palliative care cancer, in both a physical and psychological dimension



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients hospitalized in palliative care units
Criteria

Inclusion Criteria:

  • Age greater than or equal to 18 years
  • Man or woman
  • Subject who has agreed to participate in the research and to use the data collected for research purposes
  • Patient with solid cancer or hematological malignancy in palliative stage, that is to say a cancerous disease for which no curative treatment is no longer envisaged, with committed vital prognosis
  • Hospitalize patient in palliative care unit
  • Patient with indication of care in psychomotricity defined by the decree of competence Decree n ° 88-659 of May 6, 1988
  • Patient with a minimum score of 4 on an item or a minimum score of 4 on several cumulative items (with a minimum of 2 on at least one of the items), on the ESAS scale, among the following themes: pain, anxiety, depression, uneasy feeling

Exclusion Criteria:

  • Patient whose clinical condition (left to the decision of the investigator) does not allow to perform a psychomotor care and / or participate in a recorded interview (extreme fatigue, confusion, painful uncontrolled symptoms)
  • Communication difficulties, patient not speaking or not understanding French
  • Impossibility of giving the patient informed information (subject in emergency situation, difficulties in understanding the subject, etc.)
  • Patient under guardianship, curatorship
  • Patient not affiliated to social welfare regime

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03959813


Contacts
Layout table for location contacts
Contact: Marion Rousseau 03.88.11.65.80 marion.rousseau@chru-strasbourg.fr

Sponsors and Collaborators
University Hospital, Strasbourg, France

Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03959813     History of Changes
Other Study ID Numbers: 7254
First Posted: May 22, 2019    Key Record Dates
Last Update Posted: May 22, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No